Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment

Background: Understanding antiretroviral therapy (ART) adherence may assist in designing effective support interventions. Objectives: This study elicited perspectives on how to promote treatment adherence from virologically suppressed and unsuppressed patients receiving second-line ART. Methods: T...

Full description

Bibliographic Details
Main Authors: Siphamandla B. Gumede, Willem D.F. Venter, Samanta T. Lalla-Edward
Format: Article
Language:English
Published: AOSIS 2020-08-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1107
id doaj-4895d68698eb413d870c08b434d55101
record_format Article
spelling doaj-4895d68698eb413d870c08b434d551012020-11-25T03:16:27ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512020-08-01211e1e1010.4102/sajhivmed.v21i1.1107695Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatmentSiphamandla B. Gumede0Willem D.F. Venter1Samanta T. Lalla-Edward2Ezintsha, a sub-division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa; and, Department of Interdisciplinary Social Science, Public Health, Utrecht University, Utrecht, The NetherlandsEzintsha, a sub-division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, JohannesburgEzintsha, a sub-division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, JohannesburgBackground: Understanding antiretroviral therapy (ART) adherence may assist in designing effective support interventions. Objectives: This study elicited perspectives on how to promote treatment adherence from virologically suppressed and unsuppressed patients receiving second-line ART. Methods: This was a cross-sectional study conducted with randomly selected patients active on second-line ART, from five public health facilities in the Johannesburg inner city. Data were collected on demographics, clinical information, participant’s experiences and ART knowledge. Virological failure was defined as exceeding 1000 copies/mL. Results: The study sample comprised 149 participants; of which 47.7% (n = 71) were virally unsuppressed and 69.1% (n = 103) were women; the median age of the participants was 42 years (interquartile range [IQR] 36–47 years). Experiencing medication-related difficulties in taking second-line ART (p = 0.003), finding second-line regimen more difficult to take than a first-line regimen (p = 0.001) and experiencing side effects (p 0.001) were all subjective predictors of virological failure. Participants’ recommendations for improving adherence included the introduction of a single tablet regimen (31.6%, n = 55), reducing the dosage to once daily (26.4%, n = 46) and reducing the pill size for second-line regimen (4.0%, n = 7). Conclusion: The results of this study highlight the importance of improving patients’ knowledge about adherence and motivation to continue ART use despite the persistence of side effects and difficulties with taking medication.https://sajhivmed.org.za/index.php/hivmed/article/view/1107adherenceviral load suppressionvirological failureantiretroviral therapysouth africa
collection DOAJ
language English
format Article
sources DOAJ
author Siphamandla B. Gumede
Willem D.F. Venter
Samanta T. Lalla-Edward
spellingShingle Siphamandla B. Gumede
Willem D.F. Venter
Samanta T. Lalla-Edward
Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
Southern African Journal of HIV Medicine
adherence
viral load suppression
virological failure
antiretroviral therapy
south africa
author_facet Siphamandla B. Gumede
Willem D.F. Venter
Samanta T. Lalla-Edward
author_sort Siphamandla B. Gumede
title Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
title_short Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
title_full Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
title_fullStr Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
title_full_unstemmed Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
title_sort understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
publisher AOSIS
series Southern African Journal of HIV Medicine
issn 1608-9693
2078-6751
publishDate 2020-08-01
description Background: Understanding antiretroviral therapy (ART) adherence may assist in designing effective support interventions. Objectives: This study elicited perspectives on how to promote treatment adherence from virologically suppressed and unsuppressed patients receiving second-line ART. Methods: This was a cross-sectional study conducted with randomly selected patients active on second-line ART, from five public health facilities in the Johannesburg inner city. Data were collected on demographics, clinical information, participant’s experiences and ART knowledge. Virological failure was defined as exceeding 1000 copies/mL. Results: The study sample comprised 149 participants; of which 47.7% (n = 71) were virally unsuppressed and 69.1% (n = 103) were women; the median age of the participants was 42 years (interquartile range [IQR] 36–47 years). Experiencing medication-related difficulties in taking second-line ART (p = 0.003), finding second-line regimen more difficult to take than a first-line regimen (p = 0.001) and experiencing side effects (p 0.001) were all subjective predictors of virological failure. Participants’ recommendations for improving adherence included the introduction of a single tablet regimen (31.6%, n = 55), reducing the dosage to once daily (26.4%, n = 46) and reducing the pill size for second-line regimen (4.0%, n = 7). Conclusion: The results of this study highlight the importance of improving patients’ knowledge about adherence and motivation to continue ART use despite the persistence of side effects and difficulties with taking medication.
topic adherence
viral load suppression
virological failure
antiretroviral therapy
south africa
url https://sajhivmed.org.za/index.php/hivmed/article/view/1107
work_keys_str_mv AT siphamandlabgumede understandingadherenceinvirallysuppressedandunsuppressedhumanimmunodeficiencyviruspositiveurbanpatientsonsecondlineantiretroviraltreatment
AT willemdfventer understandingadherenceinvirallysuppressedandunsuppressedhumanimmunodeficiencyviruspositiveurbanpatientsonsecondlineantiretroviraltreatment
AT samantatlallaedward understandingadherenceinvirallysuppressedandunsuppressedhumanimmunodeficiencyviruspositiveurbanpatientsonsecondlineantiretroviraltreatment
_version_ 1724636067390291968